Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120016) titled 'Surgical Outcomes After Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma: Propensity-Matched Comparison of Different Curative Strategies Following TKIs plus Anti-PD-1 antibodies +/- Interventional Therapy' on March 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: SUN YAT-SEN MEMORIAL HOSPITAL
Condition:
Hepatocellular carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-15
Target Sample Size: Observational group:550;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?...